Symptomatic treatment in peripheral neuropathies

Authors

  • Desislava Bogdanova UHATNP "St.Naum"; Medical university – Sofia

Keywords:

neuropathy, pain, treatment

Abstract

Treatment of peripheral neuropathies is guided by two general principles – treatment of the underlying disease and treatment to relieve specific symptoms regardless of etiology (symptomatic treatment). The latter depends on the type of the affected peripheral nerve fibers – motor, sensory and/or autonomic. The possibilities for improving the motor symptoms are limited. There is no effective treatment for muscle weakness.
Improvement in symptoms such as cramps and fasciculations is possible. Successful medication therapy is available for autonomous symptoms such as orthostatic hypotension, gastrointestinal, urinary, sexual dysfunction and abnormal sweating.
The most successful is the management of the neuropathic
pain, which is the major problem affecting the sensory fibers of peripheral nerves. Drug treatment of neuropathic pain includes several classes of oral and topical medications. Antidepressants and antiepileptic drugs are the first choice. Despite all the advances, the symptomatic treatment for peripheral neuropathies is unsatisfactory and needs future development.

References

National Consensus on Diagnosis and Treatment of Pain from Neurological Disorders, Cephalgia, 2018, 20, Suppl. 2. https://glavobolie.org/journal/index.php/ce/issue/view/38

Barohn, R.J., Amato, A.A. Pattern-recognition approach to neuropathy and neuronopathy. Neurol Clin., 2013, 31, 2, 343-361.

Bates, D., Schultheis, B. C., Hanes, M. C., Jolly, S. M., Chakravarthy, K. V., Deer, T. R., Levy, R. M., Hunter, C. W. A Comprehensive Algorithm for Management of Neuropathic Pain. Pain medicine (Malden, Mass.), 2019, 20, Suppl. 1, S2–S12.

Boyle, J., Eriksson, M.E., Gribble, L., Gouni, R., Johnsen, S., Coppini, D.V., Kerr, D. Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: impact on pain, polysomnographic sleep, daytime functioning, and quality of life. Diabetes Care, 2012, 35, 12, 2451-2458.

Caliskan, E., Taşçı, İ., Bek, S. Gabapentin for the management of vismodegib-induced muscle cramps. Indian J Dermatol Venereol Leprol., 2017, 83, 4, 505-506.

Cozanitis, D.A., Friedmann, T., Fürst, S.. Study of the analgesic effects of galanthamine, a cholinesterase inhibitor. Arch Int Pharmacodyn Ther,. 1983, 266, 2, 229-238.

Derry, S., Sven-Rice, A., Cole, P., Tan, T., Moore, R.A. Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2013, 2, CD007393.

Egeo, G., Fofi, L., Barbanti, P. Botulinum Neurotoxin for the Treatment of Neuropathic Pain. Front Neurol., 2020, 11, 11, 716.

EFNS guidelines on neurostimulation therapy for neuropathic pain. Eur J Neurol., 2007, 14, 9, 952-970.

EFNS guidelines on the diagnosis and management of orthostatic hypotension. European Journal of Neurology, 2006, 13, 9, 930-936.

EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol., 2010, 17, 9, 1113-e88.

Ertas, M., Sagduyu, A., Arac, N., Uludag, B., Ertekin, C. Use of levodopa to relieve pain from painful symmetrical diabetic polyneuropathy. Pain, 1998, 75, 2-3, 257-259.

Garrison, S.R., Birmingham, C.L., Koehler, B.E. The effect of magnesium infusion on rest cramps: randomized controlled trial. J Gerontol A Biol Sci Med Sci., 2011, 66, 6, 661-666.

Georgiev, I., Pernov, K., Dashin, V., Iordanov, B. Our results in the treatment of myopathies and lesions of the peripheral nervous system with a new Bulgarian preparation "nivalin". Suvr Med (Sofiia), 1960, 11, 4, 16-26.

Halevy, H,, Geltner, L. Report on the effect of Nivalin (Galanthaminum hydrobromicum) on postpoliomyelitic muscles in children. Harefuah, 1962, 1, 62, 83-86.

Hone, A.J., McIntosh, J.M. Nicotinic acetylcholine receptors in neuropathic and inflammatory pain. FEBS Lett., 2018, 592, 7, 1045-1062.

Katzberg, H.D., Khan, A.H., So, Y.T. Assessment: symptomatic treatment for muscle cramps (an evidence-based review): report of the therapeutics and technology assessment subcommittee of the American academy of neurology. Neurology, 2010, 23, 74, 8, 691-696.

Lau, W. Y., Kato, H., Nosaka, K. Effect of oral rehydration solution versus spring water intake during exercise in the heat on muscle cramp susceptibility of young men. Journal of the International Society of Sports Nutrition, 2021, 18, 1, 22.

Lopate, G., Streif, E., Harms, M. Cramps and small-fiber neuropathy. Muscle Nerve., 2013, 48, 2, 252-255.

Lunn, M.P., Hughes, R.A., Wiffen, P.J. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database Syst Rev., 2014, 3, 1, CD007115.

Mijnhout, G.S., Kollen, B.J., Alkhalaf, A. Alpha lipoic Acid for symptomatic peripheral neuropathy in patients with diabetes: a metaanalysis of randomized controlled trials. Int J Endocrinol, 2012, 456279.

Moisset, X., Bouhassira, D., Avez Couturier, J., Alchaar, H., Conradi, S., Delmotte, M.H., Lanteri-Minet, M., Lefaucheur, J.P., Mick, G., Piano, V., Pickering, G., Piquet, E., Regis, C., Salvat, E., Attal, N. Pharmacological and non-pharmacological treatments for neuropathic pain: Systematic review and French recommendations. Rev Neurol (Paris)., 2020, 176, 5, 325-352.

Moore, R.A., Wiffen, P.J., Derry, S., McQuay, H.J. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2011, 16, 3, CD007938.

Paskov, D. S. Nivalin: phramacology and clinical application, Medicina i Fizkultura, Sofia, 1959.

Picone, A. The use of nivalin in the treatment of impaired hearing due to antibiotic therapy (preliminary communication). Panminerva Med., 1964, 6, 68-70.

Snedecor, S.J., Sudharshan, L., Cappelleri, J.C., Sadosky, A., Desai, P., Jalundhwala, Y., Botteman, M. Systematic review and meta-analysis of pharmacological therapies for pain associated with postherpetic neuralgia and less common neuropathic conditions. Int J Clin Pract., 2014, 68, 7, 900-918.

Swash, M., Czesnik, D., de Carvalho, M. Muscular cramp: causes and management. Eur J Neurol., 2019, 26, 2, 214-221.

Vasudevan, D., Naik, M.M., Mukaddam, Q.I. Efficacy and safety of methylcobalamin, alpha lipoic acid and pregabalin combination versus pregabalin monotherapy in improving pain and nerve conduction velocity in type 2 diabetes associated impaired peripheral neuropathic condition. Results of a pilot study. Ann Indian Acad Neurol., 2014, 17, 1, 19-24.

Wiffen, P.J., Derry, S., Moore, R.A. Lamotrigine for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev., 2013, 3, 12, CD006044.

Published

30.11.2020

How to Cite

Bogdanova, D. “Symptomatic Treatment in Peripheral Neuropathies”. Cephalgia, vol. 22, no. 1, Nov. 2020, pp. 8-14, https://glavobolie.org/journal/index.php/ce/article/view/1.

Issue

Section

CEPHALGIA